I am a
Home I AM A Search Login

Papers of the Week

Papers: 26 Nov 2022 - 2 Dec 2022

Human Studies, Pharmacology/Drug Development

2022 Nov 27


Treatment of multiple sclerosis-related trigeminal neuralgia with onabotulinumtoxinA.


Asan F, Gündüz A, Tütüncü M, Uygunoğlu U, Savrun F K, Saip S, Siva A
Headache. 2022 Nov 27.
PMID: 36437599.


The effectiveness of onabotulinumtoxinA (BTX-A) has been established in primary trigeminal neuralgia (TN). However, to the best of our knowledge, the efficacy of BTX-A in secondary TN has not yet been studied.